Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
10380883
DOI
10.1038/sj.onc.1202710
Knihovny.cz E-zdroje
- MeSH
- chybné párování bází MeSH
- dithiothreitol farmakologie MeSH
- DNA genetika metabolismus MeSH
- EDTA farmakologie MeSH
- kationty dvojmocné antagonisté a inhibitory farmakologie MeSH
- kobalt farmakologie MeSH
- kompetitivní vazba MeSH
- konsenzuální sekvence genetika MeSH
- lidé MeSH
- merkaptoethanol farmakologie MeSH
- nádorový supresorový protein p53 metabolismus MeSH
- nikl farmakologie MeSH
- protilátky MeSH
- responzivní elementy genetika MeSH
- sekvence nukleotidů MeSH
- superhelikální DNA genetika metabolismus MeSH
- vazba proteinů účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- western blotting MeSH
- zinek antagonisté a inhibitory farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- dithiothreitol MeSH
- DNA MeSH
- EDTA MeSH
- kationty dvojmocné MeSH
- kobalt MeSH
- merkaptoethanol MeSH
- nádorový supresorový protein p53 MeSH
- nikl MeSH
- protilátky MeSH
- superhelikální DNA MeSH
- zinek MeSH
Recently we have shown that wild-type human p53 protein binds preferentially to supercoiled (sc) DNA in vitro in both the presence and absence of the p53 consensus sequence (p53CON). This binding produces a ladder of retarded bands on an agarose gel. Using immunoblotting with the antibody DO-1, we show that the bands obtained correspond to ethidium-stained DNA, suggesting that each band of the ladder contains a DNA-p53 complex. The intensity and the number of these hands are decreased by physiological concentrations of zinc ions. At higher zinc concentrations, binding of p53 to scDNA is completely inhibited. The binding of additional zinc ions to p53 appears much weaker than the binding of the intrinsic zinc ion in the DNA binding site of the core domain. In contrast to previously published data suggesting that 100 microM zinc ions do not influence p53 binding to p53CON in a DNA oligonucleotide, we show that 5-20 microM zinc efficiently inhibits binding of p53 to p53CON in DNA fragments. We also show that relatively low concentrations of dithiothreitol but not of 2-mercaptoethanol decrease the concentration of free zinc ions, thereby preventing their inhibitory effect on binding of p53 to DNA. Nickel and cobalt ions inhibit binding of p53 to scDNA and to its consensus sequence in linear DNA fragments less efficiently than zinc; cobalt ions are least efficient, requiring >100 microM Co2+ for full inhibition of p53 binding. Modulation of binding of p53 to DNA by physiological concentrations of zinc might represent a novel pathway that regulates p53 activity in vivo.
Zobrazit více v PubMed
EMBO J. 1989 Jul;8(7):2087-94 PubMed
Bioessays. 1995 Jun;17(6):501-8 PubMed
J Mol Biol. 1993 Apr 5;230(3):966-78 PubMed
Curr Biol. 1994 Oct 1;4(10):865-75 PubMed
Biochemistry. 1990 Jun 19;29(24):5647-59 PubMed
Science. 1996 Feb 23;271(5252):1081-5 PubMed
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3489-94 PubMed
Biochemistry. 1987 Jun 30;26(13):3759-62 PubMed
J Mol Biol. 1996 Aug 2;260(5):623-37 PubMed
Cancer Res. 1993 Apr 15;53(8):1739-42 PubMed
Genes Dev. 1996 May 1;10(9):1054-72 PubMed
Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):579-83 PubMed
Oncogene. 1996 Apr 4;12(7):1379-85 PubMed
Oncogene. 1997 Jul 10;15(2):237-44 PubMed
Mol Carcinog. 1998 Mar;21(3):205-14 PubMed
J Mol Biol. 1995 Apr 21;248(1):58-78 PubMed
Cell. 1997 Feb 7;88(3):323-31 PubMed
J Immunol Methods. 1992 Jul 6;151(1-2):237-44 PubMed
Crit Rev Biochem Mol Biol. 1991;26(2):151-226 PubMed
Biochemistry. 1995 Nov 7;34(44):14408-15 PubMed
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10565-70 PubMed
Anal Biochem. 1976 May 7;72:248-54 PubMed
Bioessays. 1995 Nov;17(11):923-30 PubMed
Gen Pharmacol. 1994 Nov;25(7):1297-310 PubMed
Oncogene. 1995 Jan 5;10(1):27-32 PubMed
J Biol Chem. 1997 Jun 6;272(23):14842-9 PubMed
Crit Rev Biochem Mol Biol. 1991;26(5-6):475-559 PubMed
Oncogene. 1997 Oct;15(18):2201-9 PubMed
Anal Biochem. 1985 Apr;146(1):150-7 PubMed
Science. 1994 Jul 15;265(5170):346-55 PubMed
Nucleic Acids Res. 1993 Jun 11;21(11):2557-62 PubMed
Nature. 1997 Apr 10;386(6625):563 PubMed
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14338-42 PubMed
Biochim Biophys Acta. 1994 Dec 14;1209(2):279-85 PubMed
Anal Biochem. 1972 May;47(1):203-8 PubMed
Genes Dev. 1993 Dec;7(12B):2556-64 PubMed
Nucleic Acids Res. 1997 Mar 15;25(6):1289-95 PubMed
Nat Genet. 1992 Apr;1(1):45-9 PubMed
J Biol Chem. 1997 Jun 6;272(23):14830-41 PubMed
p53 Specifically Binds Triplex DNA In Vitro and in Cells
Strong preference of BRCA1 protein to topologically constrained non-B DNA structures
Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells
Role of tumor suppressor p53 domains in selective binding to supercoiled DNA